annual EBIT:
-$4.61M-$51.42M(-109.85%)Summary
- As of today (May 21, 2025), ANIP annual earnings before interest & taxes is -$4.61 million, with the most recent change of -$51.42 million (-109.85%) on December 31, 2024.
- During the last 3 years, ANIP annual EBIT has risen by +$39.53 million (+89.56%).
- ANIP annual EBIT is now -109.85% below its all-time high of $46.81 million, reached on December 31, 2023.
Performance
ANIP EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$25.47M+$33.22M(+428.79%)Summary
- As of today (May 21, 2025), ANIP quarterly earnings before interest & taxes is $25.47 million, with the most recent change of +$33.22 million (+428.79%) on March 31, 2025.
- Over the past year, ANIP quarterly EBIT has dropped by -$4.46 million (-14.91%).
- ANIP quarterly EBIT is now -14.91% below its all-time high of $29.93 million, reached on March 31, 2024.
Performance
ANIP quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$9.07M-$4.46M(-96.83%)Summary
- As of today (May 21, 2025), ANIP TTM earnings before interest & taxes is -$9.07 million, with the most recent change of -$4.46 million (-96.83%) on March 31, 2025.
- Over the past year, ANIP TTM EBIT has dropped by -$75.96 million (-113.57%).
- ANIP TTM EBIT is now -113.57% below its all-time high of $66.89 million, reached on March 31, 2024.
Performance
ANIP TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ANIP EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -109.8% | -14.9% | -113.6% |
3 y3 years | +89.6% | +232.1% | +86.2% |
5 y5 years | -128.6% | +425.2% | -325.8% |
ANIP EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -109.8% | +89.6% | -14.9% | +187.3% | -113.6% | +86.2% |
5 y | 5-year | -109.8% | +89.6% | -14.9% | +187.3% | -113.6% | +86.2% |
alltime | all time | -109.8% | +91.0% | -14.9% | +187.3% | -113.6% | +86.2% |
ANIP EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $25.47M(-428.8%) | -$9.07M(+96.8%) |
Dec 2024 | -$4.61M(-109.8%) | -$7.75M(-73.4%) | -$4.61M(-146.9%) |
Sep 2024 | - | -$29.17M(-1331.2%) | $9.83M(-82.7%) |
Jun 2024 | - | $2.37M(-92.1%) | $56.91M(-14.9%) |
Mar 2024 | - | $29.93M(+347.3%) | $66.89M(+42.9%) |
Dec 2023 | $46.81M(-235.2%) | $6.69M(-62.6%) | $46.81M(+11.7%) |
Sep 2023 | - | $17.91M(+45.0%) | $41.90M(+120.2%) |
Jun 2023 | - | $12.35M(+25.2%) | $19.03M(-448.0%) |
Mar 2023 | - | $9.86M(+454.6%) | -$5.47M(-84.2%) |
Dec 2022 | -$34.61M(-21.6%) | $1.78M(-135.9%) | -$34.61M(-44.9%) |
Sep 2022 | - | -$4.96M(-59.2%) | -$62.80M(+0.5%) |
Jun 2022 | - | -$12.15M(-37.0%) | -$62.48M(-5.3%) |
Mar 2022 | - | -$19.28M(-27.0%) | -$65.95M(+49.4%) |
Dec 2021 | -$44.14M(+167.3%) | -$26.41M(+470.1%) | -$44.14M(+151.5%) |
Sep 2021 | - | -$4.63M(-70.3%) | -$17.55M(+69.7%) |
Jun 2021 | - | -$15.62M(-717.4%) | -$10.35M(+68.3%) |
Mar 2021 | - | $2.53M(+1370.9%) | -$6.15M(-62.8%) |
Dec 2020 | -$16.51M(-202.4%) | $172.00K(-93.3%) | -$16.51M(-23.1%) |
Sep 2020 | - | $2.57M(-122.5%) | -$21.46M(+28.2%) |
Jun 2020 | - | -$11.42M(+45.9%) | -$16.74M(-516.6%) |
Mar 2020 | - | -$7.83M(+63.8%) | $4.02M(-75.1%) |
Dec 2019 | $16.12M(-53.7%) | -$4.78M(-165.6%) | $16.12M(-49.4%) |
Sep 2019 | - | $7.29M(-21.9%) | $31.87M(-8.2%) |
Jun 2019 | - | $9.34M(+118.6%) | $34.71M(+6.5%) |
Mar 2019 | - | $4.27M(-61.0%) | $32.60M(-6.3%) |
Dec 2018 | $34.81M(+22.6%) | $10.97M(+8.2%) | $34.81M(+11.5%) |
Sep 2018 | - | $10.13M(+40.1%) | $31.22M(+2.3%) |
Jun 2018 | - | $7.23M(+11.7%) | $30.51M(+0.9%) |
Mar 2018 | - | $6.48M(-12.2%) | $30.25M(+6.6%) |
Dec 2017 | $28.38M(+41.9%) | $7.38M(-21.7%) | $28.38M(+27.5%) |
Sep 2017 | - | $9.43M(+35.1%) | $22.26M(+7.4%) |
Jun 2017 | - | $6.97M(+51.4%) | $20.74M(+9.5%) |
Mar 2017 | - | $4.61M(+267.1%) | $18.94M(-5.3%) |
Dec 2016 | $20.00M(-38.9%) | $1.25M(-84.1%) | $20.00M(-20.0%) |
Sep 2016 | - | $7.90M(+52.5%) | $25.02M(-2.0%) |
Jun 2016 | - | $5.18M(-8.6%) | $25.54M(-11.2%) |
Mar 2016 | - | $5.67M(-9.6%) | $28.77M(-12.1%) |
Dec 2015 | $32.74M(+62.4%) | $6.27M(-25.6%) | $32.74M(-12.5%) |
Sep 2015 | - | $8.42M(+0.1%) | $37.40M(+0.6%) |
Jun 2015 | - | $8.41M(-12.7%) | $37.18M(+41.3%) |
Mar 2015 | - | $9.63M(-11.9%) | $26.31M(+30.3%) |
Dec 2014 | $20.17M(+3300.7%) | $10.93M(+33.3%) | $20.20M(+62.6%) |
Sep 2014 | - | $8.20M(-433.3%) | $12.42M(+146.9%) |
Jun 2014 | - | -$2.46M(-169.8%) | $5.03M(+35.4%) |
Mar 2014 | - | $3.52M(+11.7%) | $3.71M(-282.4%) |
Dec 2013 | $593.00K(-102.2%) | $3.15M(+289.5%) | -$2.04M(-77.7%) |
Sep 2013 | - | $810.00K(-121.5%) | -$9.11M(-43.4%) |
Jun 2013 | - | -$3.77M(+69.6%) | -$16.10M(-17.8%) |
Mar 2013 | - | -$2.23M(-43.3%) | -$19.59M(-28.8%) |
Dec 2012 | -$27.49M | -$3.92M(-36.5%) | -$27.51M(-8.5%) |
Sep 2012 | - | -$6.18M(-15.0%) | -$30.07M(-17.5%) |
Jun 2012 | - | -$7.27M(-28.3%) | -$36.45M(-13.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2012 | - | -$10.14M(+56.4%) | -$42.25M(-14.1%) |
Dec 2011 | -$50.93M(+11.9%) | -$6.48M(-48.4%) | -$49.19M(-14.9%) |
Sep 2011 | - | -$12.56M(-3.9%) | -$57.77M(+2.3%) |
Jun 2011 | - | -$13.06M(-23.5%) | -$56.45M(+5.3%) |
Mar 2011 | - | -$17.08M(+13.3%) | -$53.63M(+17.8%) |
Dec 2010 | -$45.51M(+18.4%) | -$15.07M(+34.1%) | -$45.51M(-17.7%) |
Sep 2010 | - | -$11.24M(+9.8%) | -$55.28M(+13.0%) |
Jun 2010 | - | -$10.24M(+14.3%) | -$48.94M(+13.0%) |
Mar 2010 | - | -$8.96M(-63.9%) | -$43.32M(+12.7%) |
Dec 2009 | -$38.43M(+113.3%) | -$24.84M(+407.0%) | -$38.43M(+148.8%) |
Sep 2009 | - | -$4.90M(+6.0%) | -$15.44M(-10.4%) |
Jun 2009 | - | -$4.62M(+13.7%) | -$17.23M(-4.9%) |
Mar 2009 | - | -$4.06M(+118.5%) | -$18.13M(+0.5%) |
Dec 2008 | -$18.01M(+107.5%) | -$1.86M(-72.2%) | -$18.03M(-0.8%) |
Sep 2008 | - | -$6.69M(+21.3%) | -$18.18M(+33.3%) |
Jun 2008 | - | -$5.51M(+39.0%) | -$13.64M(+26.8%) |
Mar 2008 | - | -$3.97M(+97.1%) | -$10.76M(+24.0%) |
Dec 2007 | -$8.68M(-352.3%) | -$2.01M(-6.3%) | -$8.68M(-366.2%) |
Sep 2007 | - | -$2.15M(-18.4%) | $3.26M(-28.2%) |
Jun 2007 | - | -$2.63M(+39.3%) | $4.54M(-6.9%) |
Mar 2007 | - | -$1.89M(-119.0%) | $4.88M(+41.8%) |
Dec 2006 | $3.44M(-137.0%) | $9.93M(-1244.3%) | $3.44M(-141.5%) |
Sep 2006 | - | -$867.50K(-62.2%) | -$8.28M(-11.6%) |
Jun 2006 | - | -$2.30M(-31.0%) | -$9.37M(-4.0%) |
Mar 2006 | - | -$3.32M(+85.5%) | -$9.76M(+4.9%) |
Dec 2005 | -$9.30M(-24.2%) | -$1.79M(-8.4%) | -$9.30M(-20.6%) |
Sep 2005 | - | -$1.96M(-27.1%) | -$11.72M(-7.8%) |
Jun 2005 | - | -$2.68M(-6.4%) | -$12.72M(+0.4%) |
Mar 2005 | - | -$2.87M(-31.9%) | -$12.66M(+3.2%) |
Dec 2004 | -$12.27M(+102.9%) | -$4.21M(+42.5%) | -$12.27M(+25.1%) |
Sep 2004 | - | -$2.95M(+12.3%) | -$9.80M(+18.3%) |
Jun 2004 | - | -$2.63M(+6.4%) | -$8.29M(+13.8%) |
Mar 2004 | - | -$2.47M(+41.6%) | -$7.29M(+20.3%) |
Dec 2003 | -$6.05M(+58.7%) | -$1.75M(+21.4%) | -$6.06M(+28.3%) |
Sep 2003 | - | -$1.44M(-11.6%) | -$4.72M(+15.6%) |
Jun 2003 | - | -$1.63M(+30.8%) | -$4.08M(+3.2%) |
Mar 2003 | - | -$1.24M(+202.6%) | -$3.96M(+3.7%) |
Dec 2002 | -$3.81M(+36.8%) | -$411.40K(-48.6%) | -$3.82M(-21.2%) |
Sep 2002 | - | -$801.00K(-46.7%) | -$4.85M(+28.9%) |
Jun 2002 | - | -$1.50M(+36.2%) | -$3.76M(+20.6%) |
Mar 2002 | - | -$1.10M(-23.4%) | -$3.12M(+13.9%) |
Dec 2001 | -$2.79M(-19.0%) | -$1.44M(-603.1%) | -$2.73M(+34.1%) |
Sep 2001 | - | $286.30K(-133.3%) | -$2.04M(-32.2%) |
Jun 2001 | - | -$858.90K(+19.0%) | -$3.01M(-16.1%) |
Mar 2001 | - | -$722.00K(-3.0%) | -$3.58M(+6.1%) |
Dec 2000 | -$3.44M(+114.2%) | -$744.40K(+9.3%) | -$3.38M(+28.3%) |
Sep 2000 | - | -$680.90K(-52.5%) | -$2.63M(+34.9%) |
Jun 2000 | - | -$1.43M(+177.8%) | -$1.95M(+131.5%) |
Mar 2000 | - | -$516.20K(+58.2%) | -$842.40K(+158.2%) |
Dec 1999 | -$1.60M(-39.7%) | - | - |
Jun 1999 | - | -$326.20K | -$326.20K |
Dec 1998 | -$2.66M | - | - |
FAQ
- What is ANI Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual EBIT year-on-year change?
- What is ANI Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly EBIT year-on-year change?
- What is ANI Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals TTM EBIT year-on-year change?
What is ANI Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of ANIP is -$4.61M
What is the all time high annual EBIT for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual earnings before interest & taxes is $46.81M
What is ANI Pharmaceuticals annual EBIT year-on-year change?
Over the past year, ANIP annual earnings before interest & taxes has changed by -$51.42M (-109.85%)
What is ANI Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of ANIP is $25.47M
What is the all time high quarterly EBIT for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly earnings before interest & taxes is $29.93M
What is ANI Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, ANIP quarterly earnings before interest & taxes has changed by -$4.46M (-14.91%)
What is ANI Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of ANIP is -$9.07M
What is the all time high TTM EBIT for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high TTM earnings before interest & taxes is $66.89M
What is ANI Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, ANIP TTM earnings before interest & taxes has changed by -$75.96M (-113.57%)